NASDAQ · Biotechnology

Skye Bioscience, Inc. Common Stock (SKYE)

$0.28 -0.14%

Add alert

18 Oversold Daily RSI (14) · 21 Aug 2026

Moving averages

SMA 200$0.92-69.57%

Company profile

Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes therapeutic drugs that modulate the endocannabinoid system. The company is headquartered in San Diego, California.

SectorHealthcare

IndustryBiotechnology

Market cap$20.39M

P/E ratioNone

EPS$-1.37

Beta2.944

Dividend yield0.00%

52-week high$4.99

52-week low$0.56

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 79 VRTX Vertex Pharmaceuticals Inc RSI 67 CRSP CRISPR Therapeutics AG RSI 67 IOVA Iovance Biotherapeutics Inc RSI 72 RXRX Recursion Pharmaceuticals Inc - Class A RSI 59 MRNA Moderna Inc RSI 72 VKTX Viking Therapeutics Inc RSI 48 SRPT Sarepta Therapeutics Inc RSI 59 EDIT Editas Medicine Inc RSI 57 NVAX Novavax Inc RSI 63

Free forever

RSI alerts for SKYE

Get an email the moment Skye Bioscience, Inc. Common Stock crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 31 July 2026 at 11:59 PM EDT